Telix Pharmaceuticals Ltd., of Melbourne, Australia, appointed Bernard Lambert president and chief operating officer of its U.S. subsidiary, Telix Pharmaceuticals (US) Inc. Read More
Genomicare Biotechnology Co. Ltd., of Shanghai, said it completed its series A financing co-launched by Morningside Venture Capital, Apricot Tree Capital and Carebridge Holdings, for which China Renaissance Group provides exclusive financial consulting service. The company provides personalized and targeted clinical solutions and global resource matching service. Read More
PERTH, Australia – Implementing drug and device regulatory reforms that were begun in 2017 will continue to be top priorities for Australia's Therapeutic Goods Administration, according to its newly published TGA Business Plan 2017-18. Read More
HONG KONG – Astrazeneca plc has teamed up with the Chinese Future Industry Investment Fund (FIIF) to form a joint venture in China for drug development via an equally owned, stand-alone company named Dizal Pharmaceutical. Read More
HONG KONG – Pfizer Inc. will bring Basilea Pharmaceutica Ltd.'s novel antifungal medicine to China and other major Asian markets as it works to meet a significant unmet need, one that is a leading cause of death across Asia. Read More
HONG KONG – Astellas Pharma Inc. is exercising its rights in a previous partnership agreement to acquire its R&D collaborator Mitobridge Inc. for $450 million. Read More
